Those who are pregnant or nursing are excluded. These constraints are more restricting than they might be for an FDA approval, In keeping with Betty Aldworth, the director of communications at MAPS.What steps could policymakers take to weigh the potential benefits and risks of psychedelics, taking into consideration policy implications, resource de